Mary Osborn

Author PubWeight™ 10.37^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Increasing the benefits and reducing the harms of prescription opioid analgesics.	Drug Alcohol Rev	2011	3.35
2	Gene silencing with siRNA duplexes composed of target-mRNA-complementary and partially palindromic or partially complementary single-stranded siRNAs.	RNA Biol	2006	0.97
3	RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome.	J Cell Sci	2005	0.95
4	Women in science.	Genome Biol	2012	0.92
5	IUBMB: the first half-century.	Trends Biochem Sci	2005	0.91
6	Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells.	Exp Cell Res	2003	0.87
7	Specific RNAi mediated gene knockdown in zebrafish cell lines.	RNA Biol	2005	0.83
8	NuMA in rat testis--evidence for roles in proliferative activity and meiotic cell division.	Exp Cell Res	2004	0.76
9	RNA interference by osmotic lysis of pinosomes: liposome-independent transfection of siRNAs into mammalian cells.	Biotechniques	2004	0.75
10	Improving the management of chronic non-malignant pain and reducing problems associated with prescription opioids.	Med J Aust	2009	0.75
11	Towards better health for refugee children and young people in Australia and New Zealand: The Royal Australasian College of Physicians perspective.	J Paediatr Child Health	2007	0.75
12	Mary Osborn. Interview by Fiona Watt.	J Cell Sci	2004	0.75